Biliary tract malignancies: a population-based study on incidence, prognosis and management of patients.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Jonasson, Jon Gunnlaugur
Jonsdottir, Sara B
Garcia, Henrik G
Möller, Pall Helgi
Björnsson, Einar S
MetadataShow full item record
CitationBiliary tract malignancies: a population-based study on incidence, prognosis and management of patients. 2016, 51 (12):1520-1525 Scand. J. Gastroenterol.
AbstractBiliary tract malignancies are uncommon and few population-based studies are available.
This nationwide population-based study in Iceland included all patients diagnosed with intra- and extrahepatic cholangiocarcinoma, gallbladder and ampullary cancer from 1984 to 2012. Patients were identified through the Icelandic Cancer Registry. Clinical information was obtained from patient records.
Overall 245 patients were identified: 38 had intrahepatic cholangiocarcinoma, 66 extrahepatic cholangiocarcinoma, 73 gallbladder cancer (GBC) and 68 ampullary cancer. Overall incidence for bile tract malignancies was 1-3 per 100,000 person-years and less than 1 by sub-type. The overall bile tract malignancies in males increased from 1.3 (95% CI 0.8-1.8) to 2.5 (1.9-3.1) per 100,000 inhabitants. The incidence of GBC among females decreased from 1.1 (0.7-1.5) to 0.5 (0.2-0.7). Surgery decreased for extrahepatic cholangiocarcinoma (56 to 23%, p = .027), ampullary cancer (80 to 48%, p = .03) and overall bile tract cancer (61 to 32%, p < .0001) but use of chemotherapy increased (4 to 32%, p < .0001). Five-year relative survival rates for men were 15% and 24% for women. No significant improvement was found in survival.
Overall incidence of bile tract malignancies increased in males and GBC decreased in women. Long-term survival is poor and did not improve despite changes in treatment.
DescriptionTo access publisher's full text version of this article click on the hyperlink at the bottom of the page
- Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013.
- Authors: Van Dyke AL, Shiels MS, Jones GS, Pfeiffer RM, Petrick JL, Beebe-Dimmer JL, Koshiol J
- Issue date: 2019 May 1
- Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997-2002.
- Authors: Goodman MT, Yamamoto J
- Issue date: 2007 May
- Increased incidence but improved median overall survival for biliary tract cancers diagnosed in Ontario from 1994 through 2012: A population-based study.
- Authors: Flemming JA, Zhang-Salomons J, Nanji S, Booth CM
- Issue date: 2016 Aug 15
- Incidence and mortality trends for biliary tract cancers in Austria.
- Authors: Pinter M, Hucke F, Zielonke N, Waldhör T, Trauner M, Peck-Radosavljevic M, Sieghart W
- Issue date: 2014 Aug
- A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
- Authors: Furuse J, Okusaka T, Ohkawa S, Nagase M, Funakoshi A, Boku N, Yamao K, Yamaguchi T, Sato T
- Issue date: 2009 Dec